Local Covid drug makers ramp up capacity
This follows companies successfully developing the formulations Favipiravir and Remdesivir, the drugs, which along with dexamethasone have been included in the Covid-19 clinical management protocol in Southeast Asia, Eastern Europe and Gulf Cooperation Council region. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 22, 2020 Category: Pharmaceuticals Source Type: news

Doctor Warns Of Risks In Rush To Embrace A COVID-19 Treatment
As researchers herald dexamethasone as a potential breakthrough treatment for critically ill patients, Dr. Kirsten Lyke says publicizing research that hasn't been rigorously vetted could erode trust.(Image credit: Simon Dawson/Bloomberg via Getty Images) (Source: NPR Health and Science)
Source: NPR Health and Science - June 20, 2020 Category: Consumer Health News Authors: Scott Simon Source Type: news

COVID-19 Update: Dexamethasone Use, Don't Forget the Fomites COVID-19 Update: Dexamethasone Use, Don't Forget the Fomites
These are the coronavirus stories you need to know about today.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - June 20, 2020 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news

Our knowledge of Covid-19 changes every day. Hindsight is misleading when it comes to science | Gideon Meyerowitz-Katz
It ’s tempting to look back and say ‘if only we had known’ – but that ignores the realitiesTheresults of a Covid-19 study have been announced. Unlike most of the previous results, this study seems immediately to be a game-changer – rather than minor benefits from an expensive drug, or spurious nonsense from a dubious trial, these results show that a cheap and common medication, dexamethasone, could reduce the risk of death in people with severe disease by a substantial amount. The study was large enough to be meaningful an d its finding likely to be true.This is, without qualification, fantastic news.Continue rea...
Source: Guardian Unlimited Science - June 19, 2020 Category: Science Authors: Gideon Meyerowitz-Katz Tags: Medical research Coronavirus outbreak Science Infectious diseases Health World Health Organization Epidemics Source Type: news

Dexamethasone for COVID-19: Some Hospitals Wait to Change Practice Dexamethasone for COVID-19: Some Hospitals Wait to Change Practice
Dexamethasone may be the first treatment shown to reduce mortality in COVID-19 patients. While some physicians were prescribing steroids already, others are still wary.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - June 19, 2020 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news

Endos Discuss Diabetic Ketoacidosis in COVID-19, Dexamethasone Endos Discuss Diabetic Ketoacidosis in COVID-19, Dexamethasone
Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that dexamethasone could reduce deaths in the severely ill.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - June 19, 2020 Category: Radiology Tags: Diabetes & Endocrinology News Source Type: news

Coronavirus Attacks the Lungs. A Federal Agency Just Halted Funding for New Lung Treatments.
The shift, quietly disclosed on a government website, highlights how the Trump administration is favoring development of vaccines over treatments for the sickest patients. (Source: NYT Health)
Source: NYT Health - June 19, 2020 Category: Consumer Health News Authors: Katie Thomas Tags: Dexamethasone (Drug) Coronavirus (2019-nCoV) Lungs Ventilators (Medical) Drugs (Pharmaceuticals) Tests (Medical) Clinical Trials Vaccination and Immunization Research Biomedical Advanced Research and Development Authority Health and Hu Source Type: news

Insight into Dexamethasone's Benefits in Severe COVID-19
The steroid's exceptional performance in early results from the RECOVERY clinical trial in the United Kingdom is a rational outcome of the drug's anti-inflammatory effects, experts say. (Source: The Scientist)
Source: The Scientist - June 19, 2020 Category: Science Tags: News & Opinion Source Type: news

Zimbabwe: COVID-19 - WHO Welcomes Death Reducing Drug
[263Chat] The World Health Organisation (WHO) has welcomed initial trial results that show dexamethasone, an anti-inflammatory medication reduces the risk of death of COVID-19 patients on ventilators and oxygen support. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 19, 2020 Category: African Health Source Type: news

Dexamethasone in the treatment of COVID-19: Implementation and management of supply for treatment in hospitals, DHSC
Dexamethasone has been demonstrated to have a clear place in the management of hospitalised patients with COVID-19. Dexamethasone was not used in pregnant women. Clinicians should therefore consider dexamethasone for the management of hospitalised patients with COVID-19 who require oxygen or ventilation. Out of hospital treatment is not appropriate.There is no current or anticipated constraint on supply of the medicine in the UK. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 18, 2020 Category: Consumer Health News Source Type: news

Advice on COVID-19 and dexamethasone steroid treatment
A new clinical trial reports that glucocorticoid, dexamethasone, is effective for treating severe COVID-19. We want to assure people that this medicine should only be taken on prescription and under the care of a doctor.Glucocorticoids are a type of anti-inflammatory medicine used to treat a range of conditions such as allergies, asthma, eczema, inflammatory bowel disease, arthritis and the endocrine condition, adrenal insufficiency. Glucocorticoids can have serious side effects and should not be taken unless necessary.Dexamethasone was reportedly only effective in COVID-19 patients on ventilators or oxygen therapy, was of...
Source: Society for Endocrinology - June 18, 2020 Category: Endocrinology Source Type: news

Dexamethasone Found to Reduce COVID-19 Deaths
JUSTIN TALLIS/AFP via Getty Images ... En espa ñol | Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A cheap, widely available steroid called dexam... (Source: AARP.org News)
Source: AARP.org News - June 18, 2020 Category: American Health Source Type: news

How dexamethasone might lead researchers to better COVID-19 treatments
The steroid dexamethasone can be lifesaving for patients with severe COVID-19. It may also help researchers learn more about the disease and how to treat it. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - June 17, 2020 Category: Science Authors: Melissa Healy Source Type: news

How dexamethasone might lead researchers to better COVID-19 treatments
The steroid dexamethasone can be lifesaving for patients with severe COVID-19. It may also help researchers learn more about the disease and how to treat it. (Source: L.A. Times - Health)
Source: L.A. Times - Health - June 17, 2020 Category: Consumer Health News Authors: Melissa Healy Source Type: news

Indian drug firms cheer dexamethasone efficacy on severe COVID-19 patients
M P Gupta, general manager of Mahima Lifesciences, a Chandigarh-based steroid API maker, said the company was expecting a jump in raw material costs and possible supply disruption if demand goes up. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 17, 2020 Category: Pharmaceuticals Source Type: news